Wangchuk, Phurpa, Yeshi, Karma, and Loukas, Alex (2024) Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends in Pharmacological Sciences, 45 (10). pp. 892-903.

PDF (Published Version) - Published Version Restricted to Repository staff only

Abstract

Ulcerative colitis (UC) is one of the two forms of inflammatory bowel disease. It affects 5 million people globally, and is a chronic and recurring inflammation of the gastrointestinal tract with clinical presentation of abdominal pain, chronic diarrhea, rectal bleeding, and weight loss. The cause and the etiology of UC remain poorly understood. There is no cure and no ‘gold standard diagnostic’ for UC. The existing treatments are ineffective, and UC patients have a lower life expectancy with a risk of colorectal cancer. Recent studies in pathophysiology, clinical presentation, and biomarkers have significantly improved our understanding of UC. In this review we summarize recent advances in identifying novel clinical biomarkers, diagnostics, treatment targets, and emerging therapeutics. These insights are expected to assist in developing effective treatments for UC.

Item ID:	83799
Item Type:	Article (Research - C1)
ISSN:	1873-3735
Keywords:	clinical biomarkers,diagnosis,emerging treatment,inflammatory bowel disease,therapeutic target,ulcerative colitis
Related URLs:	https://www.scopus.com/inward/record.uri...
Copyright Information:	© 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Funders:	National Health and Medical Research Council (NHMRC)
Projects and Grants:	NHMRC Ideas grant (APP1183323), NHMRC investigator grant (2008450)
Date Deposited:	14 Oct 2024 22:06
Downloads:	Total: 1 Last 12 Months: 1
	More Statistics